NCT03770598

Brief Summary

Researchers are trying to see if proactive identification and team based individualized care of cancer patients having emotional difficulties can improve quality of life relative to treatment as usual. Also, to see if proactive approaches to maintain wellness can prevent grief among breast cancer patients, experiencing no emotional difficulties relative to treatment as usual.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable breast-cancer

Timeline
Completed

Started Nov 2018

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 19, 2018

Completed
9 days until next milestone

Study Start

First participant enrolled

November 28, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 10, 2018

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 16, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 16, 2021

Completed
Last Updated

April 19, 2024

Status Verified

April 1, 2024

Enrollment Period

3 years

First QC Date

November 19, 2018

Last Update Submit

April 18, 2024

Conditions

Keywords

Psychosocial CareWellness

Outcome Measures

Primary Outcomes (1)

  • Change in Wellness

    Subject wellness scores based on Short Warwick-Edinburgh Mental-Wellbeing Scale. This is a 7 item scale monitoring of mental wellbeing in subjects. Responses are based on a 1 to 5 item scale with 1 = None of the time, 2 = Rarely, 3 = Some of the Time, 4 = Often, 5 = All of the Time.

    baseline, 6 months

Secondary Outcomes (2)

  • Improvement in depression compared to baseline

    one year

  • Improvement in anxiety compared to baseline

    One Year

Study Arms (2)

Distressed

ACTIVE COMPARATOR

Study participants who do indicate distress or who do meet criteria for depression or anxiety will be randomized to receive either treatment as usual (referral to Psychiatry or Psychology for evaluation and further treatment) or team based care model.

Behavioral: Standard of Care Distressed in study Arm DistressedBehavioral: Team Based Care

Non-Distressed

ACTIVE COMPARATOR

Study participants who do not indicate distress or who do not meet criteria for depression or anxiety will be randomize to monitoring only or to receive psycho-education regarding subjects that when used can promote wellness.

Behavioral: Psycho-EducationBehavioral: Standard of Care Non-Distressed

Interventions

Social worker evaluation and possible referral to Psychiatry/Psychology for evaluation and further treatment.

Distressed

Mindfulness based stress reduction class, yoga and education material

Non-Distressed
Team Based CareBEHAVIORAL

Psychiatrist, Oncologist, clinical social worker, study coordinator

Distressed

No psycho-education about wellness promotion or health. These patients will be monitored only.

Non-Distressed

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of breast cancer within last three years
  • Able to communicate in English or with the help of an interpreter.
  • Access to a device with internet connection

You may not qualify if:

  • Breast cancer patients who are considered for hospice or expected survival of less than six months.
  • Presence of active suicidal ideations.
  • Presence of active psychosis.
  • Presence of dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Jacksonville, Florida, 32081, United States

Location

Related Links

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Shehzad K Niazi

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Non-Distressed patients will be randomized to receive intervention or standard of care. Distressed patients will be randomized to receive intervention or standard of care
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prinicpal Investigator

Study Record Dates

First Submitted

November 19, 2018

First Posted

December 10, 2018

Study Start

November 28, 2018

Primary Completion

November 16, 2021

Study Completion

November 16, 2021

Last Updated

April 19, 2024

Record last verified: 2024-04

Locations